Suppr超能文献

伴有胃肠道表现的单器官和多系统嗜酸性粒细胞增多综合征患者具有共同特征。

Single-Organ and Multisystem Hypereosinophilic Syndrome Patients with Gastrointestinal Manifestations Share Common Characteristics.

作者信息

Kuang Fei Li, Curtin Bryan F, Alao Hawwa, Piligian Brent, Berry Alexis, Holland-Thomas Nicole, Powers Astin, Quezado Martha, Lumbard Keith, Fay Michael P, Klion Amy D, Kumar Sheila, Khoury Paneez

机构信息

Laboratory of Parasitic Diseases, NIAID, Bethesda, Md; Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, Ill.

Digestive Diseases Branch, NIDDK, National Institutes of Health, Bethesda, Md.

出版信息

J Allergy Clin Immunol Pract. 2020 Sep;8(8):2718-2726.e2. doi: 10.1016/j.jaip.2020.04.025. Epub 2020 Apr 25.

Abstract

BACKGROUND

Eosinophilic gastrointestinal diseases (EGIDs) are defined by marked eosinophilia in the gastrointestinal (GI) tract resulting in a wide variety of GI symptoms. When accompanied by blood hypereosinophilia (HE; absolute eosinophil count ≥1500/mm), EGID can occur as an isolated GI disorder (hypereosinophilic syndrome [HES]/EGID overlap) or as part of a multisystem hypereosinophilic syndrome (Multisystem HES).

OBJECTIVE

To describe the GI disease of patients categorized as those with HES/EGID overlap versus those with Multisystem HES.

METHODS

Consecutively enrolled patients on a natural history protocol to study eosinophilia with biopsy-proven EGID involving the esophagus, stomach, small-bowel, and/or colon were evaluated for clinical, histopathologic, and endoscopic features by retrospective chart review.

RESULTS

Among the 56 patients with EGID and HE, 34 were categorized as HES/EGID overlap and 22 as Multisystem HES. Demographics, GI symptoms, and associated comorbidities were similar between the 2 groups. Multisegment GI eosinophilia was present in 20 of 30 (67%) patients who underwent tissue sampling of all 4 GI segments. Tissue eosinophilia in all 4 GI segments was found in 5 of 30 (17%) patients. Dietary therapy was more common in patients with HES/EGID overlap (65% vs 23%, P = .0028). Patients with Multisystem HES were more likely to receive glucocorticoids (100% vs 79%, P = .0349) and nonglucocorticoid systemic therapies (77% vs 38%, P = .0061). One-third (8 of 22) of patients with Multisystem HES presented with isolated GI symptoms before developing extraintestinal manifestations at a median of 1 year (range, 0.25-15 years).

CONCLUSION

There are striking clinical similarities between patients with Multisystem HES and those with HES/EGID overlap, despite differing treatment approaches. Moreover, Multisystem HES can present with isolated GI involvement. Larger prospective studies are needed to confirm these findings.

摘要

背景

嗜酸性粒细胞性胃肠疾病(EGIDs)的定义是胃肠道(GI)中显著的嗜酸性粒细胞增多,导致多种胃肠道症状。当伴有血液嗜酸性粒细胞增多(HE;绝对嗜酸性粒细胞计数≥1500/mm)时,EGID可作为一种孤立的胃肠道疾病(嗜酸性粒细胞增多综合征[HES]/EGID重叠)出现,或作为多系统嗜酸性粒细胞增多综合征(多系统HES)的一部分出现。

目的

描述归类为HES/EGID重叠患者与多系统HES患者的胃肠道疾病情况。

方法

通过回顾性病历审查,对连续纳入自然病史方案以研究嗜酸性粒细胞增多且经活检证实患有涉及食管、胃、小肠和/或结肠的EGID的患者进行临床、组织病理学和内镜特征评估。

结果

在56例患有EGID和HE的患者中,34例归类为HES/EGID重叠,22例归类为多系统HES。两组患者的人口统计学、胃肠道症状和相关合并症相似。在对所有4个胃肠道节段进行组织采样的30例患者中,20例(67%)存在多节段胃肠道嗜酸性粒细胞增多。30例患者中有5例(17%)在所有4个胃肠道节段均发现组织嗜酸性粒细胞增多。饮食疗法在HES/EGID重叠患者中更为常见(65%对23%,P = 0.0028)。多系统HES患者更有可能接受糖皮质激素治疗(100%对79%,P = 0.0349)和非糖皮质激素全身治疗(77%对38%,P = 0.0061)。多系统HES患者中有三分之一(22例中的8例)在出现肠外表现之前出现孤立的胃肠道症状,中位时间为1年(范围为0.25 - 15年)。

结论

尽管治疗方法不同,但多系统HES患者与HES/EGID重叠患者在临床上有显著相似之处。此外,多系统HES可表现为孤立的胃肠道受累。需要更大规模的前瞻性研究来证实这些发现。

相似文献

1
Single-Organ and Multisystem Hypereosinophilic Syndrome Patients with Gastrointestinal Manifestations Share Common Characteristics.
J Allergy Clin Immunol Pract. 2020 Sep;8(8):2718-2726.e2. doi: 10.1016/j.jaip.2020.04.025. Epub 2020 Apr 25.
3
Eosinophilic gastrointestinal disorders (EGID) with peripheral eosinophilia: a retrospective review at Mayo Clinic.
Dig Dis Sci. 2011 Nov;56(11):3254-61. doi: 10.1007/s10620-011-1754-3. Epub 2011 Jun 8.
5
Role of peripheral and tissue eosinophils and eosinophil cationic protein in pediatric inflammatory bowel disease.
J Pediatr Gastroenterol Nutr. 2024 Mar;78(3):653-661. doi: 10.1002/jpn3.12076. Epub 2023 Dec 10.
6
Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease.
J Allergy Clin Immunol Pract. 2022 Jun;10(6):1598-1605.e2. doi: 10.1016/j.jaip.2022.02.037. Epub 2022 Mar 10.
7
Case of hypereosinophilic syndrome with gastrointestinal involvement showing tissue eosinophil cytolysis.
Asia Pac Allergy. 2022 Oct 17;12(4):e37. doi: 10.5415/apallergy.2022.12.e37. eCollection 2022 Oct.
8
Eosinophilic Gastrointestinal Diseases in Childhood.
Ann Nutr Metab. 2018;73 Suppl 4:18-28. doi: 10.1159/000493668. Epub 2019 Feb 19.
9
Eosinophilic gastrointestinal disorders associated with autoimmune connective tissue disease.
Joint Bone Spine. 2016 Oct;83(5):479-84. doi: 10.1016/j.jbspin.2015.11.006. Epub 2015 Dec 19.
10
Primary Eosinophilic Gastrointestinal Diseases Beyond Eosinophilic Esophagitis in Children.
J Pediatr Gastroenterol Nutr. 2021 Feb 1;72(2):294-299. doi: 10.1097/MPG.0000000000002925.

引用本文的文献

1
Burden of hypereosinophilic syndromes in the United States: Patients' perspective.
J Allergy Clin Immunol Glob. 2025 May 28;4(3):100501. doi: 10.1016/j.jacig.2025.100501. eCollection 2025 Aug.
3
Hypereosinophilia: clinical and therapeutic approach in 2025.
Curr Opin Allergy Clin Immunol. 2025 Aug 1;25(4):258-268. doi: 10.1097/ACI.0000000000001078. Epub 2025 May 21.
6
8
Distinct CRTH2+CD161+ (peTh2) memory CD4+ T-cell cytokine profiles in food allergy and eosinophilic gastrointestinal disorders.
Clin Exp Allergy. 2023 Oct;53(10):1031-1040. doi: 10.1111/cea.14376. Epub 2023 Jul 24.
9
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes.
Orphanet J Rare Dis. 2023 Apr 30;18(1):100. doi: 10.1186/s13023-023-02696-4.
10
Hypereosinophilic syndrome presenting with gastrointestinal manifestations.
BMJ Case Rep. 2023 Apr 4;16(4):e254388. doi: 10.1136/bcr-2022-254388.

本文引用的文献

2
Consortium of Eosinophilic Gastrointestinal Disease Researchers: Advancing the Field of Eosinophilic GI Disorders Through Collaboration.
Gastroenterology. 2019 Mar;156(4):838-842. doi: 10.1053/j.gastro.2018.10.057. Epub 2018 Nov 17.
3
Elevated Tryptase in EoE Is an Independent Phenomenon Associated with Extra-Esophageal Symptoms.
Dig Dis Sci. 2019 Jan;64(1):152-157. doi: 10.1007/s10620-018-5298-7. Epub 2018 Sep 28.
4
Revisiting the NIH Taskforce on the Research needs of Eosinophil-Associated Diseases (RE-TREAD).
J Leukoc Biol. 2018 Jul;104(1):69-83. doi: 10.1002/JLB.5MR0118-028R. Epub 2018 Apr 19.
5
Eosinophilic Gastrointestinal Disorders Pathology.
Front Med (Lausanne). 2018 Jan 15;4:261. doi: 10.3389/fmed.2017.00261. eCollection 2017.
7
(A Critical Appraisal of) Classification of Hypereosinophilic Disorders.
Front Med (Lausanne). 2017 Dec 5;4:216. doi: 10.3389/fmed.2017.00216. eCollection 2017.
9
UpSetR: an R package for the visualization of intersecting sets and their properties.
Bioinformatics. 2017 Sep 15;33(18):2938-2940. doi: 10.1093/bioinformatics/btx364.
10
Prevalence of Eosinophilic Gastroenteritis and Colitis in a Population-Based Study, From 2012 to 2017.
Clin Gastroenterol Hepatol. 2017 Nov;15(11):1733-1741. doi: 10.1016/j.cgh.2017.05.050. Epub 2017 Jun 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验